中国批准首个植入式脑机接口

China Approves First Implantable Brain-Computer Interface
中国批准首个植入式脑机接口

China has approved its first implantable brain-computer interface (BCI), developed by Neuracle Medical Technology, marking a major step in the country’s neurotechnology ambitions. The device is designed to help patients with spinal cord injuries regain hand movement. Regulators say it is the world’s first invasive BCI approved as a commercial medical product. The breakthrough highlights growing momentum among Chinese BCI start-ups, which are often viewed as potential rivals to Neuralink, the brain-chip firm founded by Elon Musk. Following the announcement, shares of related companies surged, including Inkon Life Technology in Shenzhen. Founded in 2011 by biomedical engineer Xu Honglai, Neuracle is also preparing for a public listing in Shanghai.

中国批准了首个植入式脑机接口（BCI），由Neuracle Medical Technology开发，标志着中国在神经科技领域迈出重要一步。该设备旨在帮助脊髓损伤患者恢复手部运动能力。监管机构表示，这是全球首个获准作为商业医疗产品销售和用于患者的侵入式脑机接口。这一突破凸显了中国脑机接口初创企业的快速发展，它们常被视为Neuralink的潜在竞争者，而该公司由Elon Musk创立。消息公布后，相关公司股价上涨，包括深圳上市的Inkon Life Technology。Neuracle由生物医学工程师Xu Honglai于2011年创立，目前也在准备于上海上市。

脑机接口